HTER

CRIPTOCURRENCY FOR A LONGER LIFE

INVESTORS PITCH DECK www.hter.io

FORWARD LOOKING STATEMENTS Coutionary Regarding Forward-Looking Information

This prLesenetatigon acontlains Dstatemiesntcs wlhaich icmonstituete r“forward-looking information” within the meaning of applicable securities laws, including statements

regarding the plans, intentions, beliefs and current expectations of Hter.io (biogen international business company) with respect to future business activities and

operating performance. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”,

“estimate”, “expect” or similar expressions and include information regarding: (i) the amount of future revenue over any period; (ii) assumptions relating to

revenues, operating cash flow and other revenue metrics set out in the Company's disclosure materials; and (iii) future development plans (iv) any unintended

disruption of operations and effects thereof . Investors are cautioned that forward-looking information is not based on historical facts but instead reflect

Hter.io (biogen international business company) management’s expectations, estimates or projections concerning future results or events based on the

opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although Hter.io (biogen international business company) believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue

reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or

achievements of the company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking

information are the following: the ability of Hter to successfully integrate the operations and employees of its operations, and realize synergies and cost savings,

and to the extent, anticipated; the potential impact on development activities; the potential impact on relationships, including with regulatory bodies, employees,

suppliers, customers and competitors; changes in general economic, business and political conditions, including changes in the financial markets; changes in

applicable laws; and compliance with extensive government regulation. This forward-looking information may be affected by risks and uncertainties in the

business of Hter.io (biogen international business company) and market conditions. This information is qualified in its entirety by cautionary statements and risk

factor disclosure contained in filings made by Hter.io (biogen international business company). Should one or more of these risks or uncertainties materialize, or

should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended,

planned, anticipated, believed, estimated or expected. Although Hter has attempted to identify important risks, uncertainties and factors which could cause

actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended.

Hter.io (biogen international business company) does not intend, and do not assume any obligation, to update this forward-looking information except as otherwise required by applicable law. All dollar amounts in this presentation are expressed in U.S. Dollars unless otherwise noted. This data is furnished to provide

additional information and are non-IFRS measures and do not have any standardized meaning prescribed by International Financial Reporting Standards (“IFRS”).

These measures should not be considered in isolation as a substitute for measures of performance prepared in accordance with IFRS and are not necessarily

indicative of anything presented under IFRS.

We insist the blockchain technology is in full development and we do not know how it will develop, this technology and the tokens that we use have seen that

they change their value easily and are very volatile.

The company Hter.io (biogen international business company) will investigate, contract or reach agreements with biologists or companies that study how to extend human life, we remind all investors to take into account and study and make inquiries and that according to their research and seeing our project decide

whether or not they want to exchange their tokens for ours.

HTER

What is HTER

What is the project of Hter.io ?

The project is based on the search for an effective method to extend human life.

We will mainly investigate the most effective method to lengthen or avoid the

reduction of telomere size without damaging other cells or the health and human integrity.

Where and who will carry out the project?

The company responsible for the project is Hter.io (Biogen international business company) based in

the Ireland and has the collaboration of scientists and experts in molecular bio-medicine around

the world.

HTER

2 Billion Potential

Customers.

Market Overview

There is no competition.

Nobody today

has managed

to extend

human life

The Aging...

...is related

to many

other diseases

HTER

Opportunity Great advances in this field,

lack of capital for research,

possible agreements

with renowned scientists.

HTER

The problem

Today we have been able to extend

the life of mice by 40%. Now it is

necessary to carry out tests in humans,

but death is not considered a disease, so

you can not perform tests in humans

just for the sake of prolonging life.

HTER

The solution

Experiment with humans who have degenerative

diseases, but for that it is necessary to reach agreements

with hospitals and renowned scientists who need these

funds to complete their research.

Thanks to the Blockchain technology, we can collect

those funds and have small investors exchange tokens

for ours, which will then be used to verify that the

address of the electronic wallet and the email are from

the same person and can access the page of Hter or

perhaps another laboratory, company or scientist with

whom an agreement has been reached.

We remind our investors that the Hter tokens are not a

value in any case. The Hter tokens were created in order

to be used to make certain verifications and have their

own copyright and can only be reproduced under the

terms of the Hapache license that appeared on our

website.

HTER

Token sale details HTER token sale will take place from 01

September, 2020 to April 30, 2020, This

period may be lengthened if the company

so deems it convenient until a maximum

deadline of December 30/2021

HTER

DISTRIBUTION 5.000.000.000

TOKENS HTER

Buyers of our Hter token will have a discount in the sales

period of 15%, after the sale period there is a possibility that

our tokens are in a token exchange

HTER

Use of funds

• Scientific agreements, or private institutions, salaries, payments

for sales, hiring and facilities for the development the activity: 70%

• Business Development and Mar 20%

• Legal and Accounting: 5%.

• Miscellaneous: 5%

HTER

Join Us Today HTER

Our web page:

Token Sale:

White Paper:

Blog:

https://hter.io

https://hter.io/ico-initial-coin-offering-token-sale

https://hter.io//ico-initial-coin-offering-white-paper

https://hter.io//ico-initial-coin-offering-blog

HTER

HTER

CRIPTOCURRENCY FOR A LONGER LIFE

Thanks for your interest

w w w . h t e r . i o

HTER